CAS 1388651-30-6

Formel: C19H18F3N5O2S

InChl: InChI=1S/C19H18F3N5O2S/c1-9-12-7-30-18(23)27-19(12,8-29-9)11-4-10(2-3-13(11)20)26-17(28)15-6-24-14(5-25-15)16(21)22/h2-6,9,12,16H,7-8H2,1H3,(H2,23,27)(H,26,28)/t9-,12-,19-/m1/s1

InChI Key: AACUJFVOHGRMTR-DPXNYUHVSA-N

SMILES: C[C@@H]1[C@H]2CSC(=N[C@]2(CO1)C3=C(C=CC(=C3)NC(=O)C4=NC=C(N=C4)C(F)F)F)N

Elenbecestat

CAS: 1388651-30-6

Elenbecestat (E2609) is an effective oral bioutilization and CNS penetrating ACE-1 inhibitor for the treatment of Alzheimer's disease.

Formel: C₁₉H₁₈F₃N₅O₂S

Reinheit: 99.95%

Farbe und Form: White Solid

Molekulargewicht: 437.439

Ref: TM-T11175

Elenbecestat

CAS: 1388651-30-6

Elenbecestat

Formel: C₁₉H₁₈F₃N₅O₂S

Reinheit: 99.5%

Molekulargewicht: 437.44

Ref: 54-BUP09627

Elenbecestat

CAS: 1388651-30-6

Formel: C₁₉H₁₈F₃N₅O₂S

Reinheit: 98%

Molekulargewicht: 437.4387

Ref: IN-DA01V4DE

Elenbecestat

CAS: 1388651-30-6

N-(3-((4aS,5R,7aS)-2-Amino-5-methyl-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl)-4-fluorophenyl)-5-(difluoromethyl)pyrazine-2-carboxamide

Formel: C₁₉H₁₈F₃N₅O₂S

Reinheit: 98%

Molekulargewicht: 437.44

Ref: IN-DG01132716

Elenbecestat

CAS: 1388651-30-6

Elenbecestat is a monoclonal antibody that inhibits the enzyme acetylcholinesterase (AChE), which degrades the neurotransmitter acetylcholine. Elenbecestat has been shown to be effective in reducing insulin resistance and improving glucose tolerance in mice. Clinical trials have shown that elenbecestat is safe for use in humans, with few side effects. Elenbecestat has also been shown to reduce fatty acids and protofibril formation in vitro. It also acts as an esterase inhibitor, preventing the hydrolysis of phospholipids. This drug may cause allergic reactions.

Formel: C₁₉H₁₈F₃N₅O₂S

Reinheit: Min. 95%

Molekulargewicht: 437.44 g/mol

Ref: 3D-NFC65130